Angiographic variables predict increased risk for adverse ischemic events after coronary stenting with glycoprotein IIb/IIIa inhibition: results from the TARGET trial. - Ross MJ; Herrmann HC; Moliterno DJ; Blankenship JC; Demopoulos L; DiBattiste PM; Ellis SG; Ghazzal Z; Martin JL; White J; Topol EJ; Ross, Mitchell J; et al. (Journal of the American College of Cardiology (JACC), 2003)